S2Medical AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	0.91	1	1.52	3.72	9.48
Cash & Short-Term Investments	0.91	1	1.52	3.72	9.48
Cash Growth	-9.73%	-33.78%	-59.25%	-60.72%	-62.56%
Accounts Receivable	0.69	2.16	1.44	1.22	0.75
Other Receivables	0.23	0.17	0.38	0.41	0.51
Total Trade Receivables	0.92	2.33	1.82	1.63	1.26
Inventory	3.01	4.37	5.16	6.39	4.62
Other Current Assets	0.76	0.78	0.13	0.19	0.9
Total Current Assets	3.96	5.79	8.63	11.93	16.26
Net Property, Plant & Equipment	0.2	0.43	0.75	1.19	1.74
Other Intangible Assets	12.55	11.14	10.94	10.85	9.97
Goodwill	0.19	0.57	0.95	1.32	1.7
Long-Term Investments	0	7.42	-	-	-
Total Assets	16.9	25.36	21.41	25.29	29.68
Accounts Payable	0.91	0.36	3.47	1.77	0.99
Accrued Expenses	3.09	3.63	2.89	2.67	2.96
Current Portion of Long-Term Debt	0	0	0	0	0.21
Unearned Revenue	0.14	0	2.17	0.23	0.11
Other Current Liabilities	2.89	2.65	11.22	13.55	10.73
Total Current Liabilities	7.03	6.64	19.75	18.23	15
Total Liabilities	7.03	6.64	19.75	18.23	15
Common Stock	1.57	1.47	16.14	1.9	0.88
Additional Paid-in Capital	121.49	120.34	120.18	104.44	83.55
Retained Earnings	-113.19	-103.08	-134.66	-99.27	-69.75
Shareholders' Equity	9.87	18.72	1.66	7.07	14.68
Total Liabilities & Equity	16.9	25.36	21.41	25.29	29.68
Total Debt	0	0	0	0	0.21
Net Cash (Debt)	0.91	1	1.52	3.72	9.27
Net Cash Growth	-9.73%	-33.78%	-59.25%	-59.85%	-62.14%
Net Cash Per Share	0.00	0.00	0.01	0.16	0.63
Book Value	9.87	18.72	1.66	7.07	14.68
Book Value Per Share	0.01	0.03	0.01	0.30	0.99
Tangible Book Value	-2.86	7.01	-10.23	-5.11	3.01
Tangible Book Value Per Share	-0.00	0.01	-0.08	-0.21	0.20